参考文献/References:
[1] Otsuka F,Yasuda S,Noguchi T,et al. Pathology?f coronary?therosclerosis?nd thrombosis[J]. Cardiovasc Diagn Ther,2016,6(4):396-408.[2] Huang Y,Liu L,Liu A,et al. Dickkopf-1:current knowledge and related diseases[J]. Life Sci,2018,209:249-254. [3] Foulquier S,Daskalopoulos EP,Lluri G,et al. WNT signaling in cardiac and vascular disease[J]. Pharmacol Rev,2018,70(1):68-141. [4] Gay A,Towler DA. Wnt signaling in cardiovascular disease:opportunities and challenges[J]. Curr Opin Lipidol,2017,28(5):387-396.[5]Du J,Li J. The role of Wnt signaling pathway in atherosclerosis and its relationship with angiogenesis[J]. Exp Ther Med,2018,16(3):1975-1981.[6]Jeong W, Jho EH. Regulation of the low-density lipoprotein receptor-related protein LRP6 and its association with disease:Wnt/β-catenin signaling and beyond[J]. Front Cell Dev Biol,2021,9:714330.[7] Baetta R,Banfi C. Dkk (Dickkopf) proteins[J]. Arterioscler Thromb Vasc Biol.,2019,39(7):1330-1342.[8]Go GW. Low-density lipoprotein receptor-related protein 6 (LRP6) is a novel nutritional therapeutic target for hyperlipidemia,non-alcoholic fatty liver disease,and atherosclerosis[J]. Nutrients,2015,7(6):4453-4464.[9] Bengoa-Vergniory N,?orro?-Etxebarria I. A switch from canonical to noncanonical?nt?ignaling?ediates early differentiation of human neural stem cells[J]. Stem Cells,2014,32(12):3196-3208. [10] Ueland T,Otterdal K,Lekva T,et al. Dickkopf-1 enhances inflammatory interaction between platelets and endothelial cells and shows increased expression in atherosclerosis[J]. Arterioscler Thromb Vasc Biol,2009,29(8):1228-1234. [11] Borrell-Pagès M,Romero JC,Badimon L. LRP5 deficiency down-regulates Wnt signalling and promotes aortic lipid infiltration in hypercholesterolaemic mice[J]. J Cell Mol Med,2015,19(4):770-777. [12]Di M,Wang L,Li M,et al. Dickkopf1 destabilizes atherosclerotic plaques and promotes plaque formation by inducing apoptosis of endothelial cells through activation of ER stress[J]. Cell Death Dis,2017,8(7):e2917.[13]Lattanzio S,?antilli F,Liani R,et al. Circulating dickkopf-1 in diabetes mellitus:association with platelet activation and effects of improved metabolic control and low-dose aspirin[J]. J Am Heart Assoc,2014,3(4):e001000. [14]Chae WJ,Bothwell A LM. Dickkopf1:an immunomodulatory ligand and Wnt antagonist in pathological inflammation[J]. Differentiation,2019,108:33-39. [15] Szulc P,?choppet M,?achner TD,et al. Severe abdominal aortic calcification in older men is negatively associated with DKK1 serum levels:the STRAMBO study[J]. J Clin Endocrinol Metab,2014,99(2):617-624.[16]Register TC,?ruska KA,Divers J,et al. Plasma Dickkopf1 (DKK1) concentrations negatively associate with atherosclerotic calcified plaque in African-Americans with type 2 diabetes[J]. J Clin Endocrinol Metab,2013,98(1):E60-E65.[17] Hampson G,?dwards S,?onroy S,et al. The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin),bone mineral density,vascular calcification and arterial stiffness in post-menopausal women[J]. Bone,2013,56(1):42-47. [18] Evenepoel P,?aese PD,?randenburg V. Sclerostin and DKK1:new players in renal bone and vascular disease[J]. Kidney Int,2015,88(2):235-240. [19]Motovska Z,Vichova T,Doktorova M,et al. Serum Dickkopf-1 signaling and calcium deposition in aortic valve are significantly related to the presence of concomitant coronary atherosclerosis in patients with symptomatic calcified aortic stenosis[J]. J Transl Med,2015,13:63.[20] Pontremoli M,Brioschi M,Baetta R,et al. Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells[J]. Sci Rep,2018,12,8(1):16671. [21]Rakipovski G,Rolin B,Barascuk N. A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis:Is the therapeutic potential lost in translation?[J]. Atherosclerosis,2020,314:1-9. [22]Wang L,Hu XB,Zhang W,et al. Dickkopf-1 as a novel predictor is associated with risk stratification by GRACE risk scores for predictive value in patients with acute coronary syndrome:a retrospective research[J]. PLoS One,2013,8(1):e54731. [23] Ueland T,?erblom A,Ghukasyan T,et al. Admission levels of DKK1 (Dickkopf-1) are associated with future cardiovascular death in patients with acute coronary syndromes[J]. Arterioscler Thromb Vasc Biol,2019,39(2):294-302. [24]Klingenschmid G,Tschiderer L,Himmler G,et al. Associations of serum Dickkopf-1 and sclerostin with cardiovascular events:results from the prospective Bruneck study[J]. J Am Heart Assoc,2020,9(6):e014816. [25]Wang L,Liu S,Niu J,et al. Serum Dickkopf-3 level is inversely associated with significantcoronary stenosis in an asymptomatic Chinese cohort[J]. Int Heart J,2020,61(6):1107-1113.?26]Karamariti E,Zhai C,Yu B,et al. DKK3 (Dickkopf 3) alters atherosclerotic plaque phenotype involving vascular progenitor and fibroblast differentiation into smooth muscle cells[J]. Arterioscler Thromb Vasc Biol,2018,38(2):425-437.[27]Chen T,Karamariti E,Hong X,et al. DKK3 (Dikkopf-3) transdifferentiates fibroblasts into functional endothelial cells—Brief report[J]. Arterioscler Thromb Vasc Biol,2019,39(4):765-773.[28]Zhu Z,Guo D,Zhong C,et al. Serum dickkopf-3 is associated with death and vascular events after ischemic stroke:an observational study from CATIS[J]. J Neuroinflammation,2020,17(1):12.[29]Lou X,Meng Y,Hou Y. A literature review on function and regulation mechanism of DKK4[J]. J Cell Mol Med,2021,25(6):2786-2794.[30]Zhang Y,Wu H,He R,et al. Dickkopf-2 knockdown protects against classic macrophage polarization and lipid loading by activation of Wnt/β-catenin signaling[J]. J Cardiol,2021,78(4):328-333.Li F,Yan K,Wu L,et al. Single-cell RNA-seq reveals cellular heterogeneity of mouse carotid artery under disturbed flow[J]. Cell Death Discov,2021,7(1):180.
相似文献/References:
[1]李乐亮,综述,李萍,等.炎症标志物与颈动脉粥样斑块的稳定性[J].心血管病学进展,2016,(3):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
LI Leliang,LI Ping.Stability of Inflammatory Markers and Carotid Artery Plaque[J].Advances in Cardiovascular Diseases,2016,(2):219.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.001]
[2]耿春晖 关秀茹.MicroRNA作为动脉粥样硬化的诊断生物标志物的研究进展[J].心血管病学进展,2019,(7):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
GENG Chunhui,GUAN Xiuru.microRNA as a Diagnostic Biomarker for Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(2):996.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.008]
[3]乐健 何胜虎.前蛋白转化酶枯草溶菌素9致动脉粥样硬化的机制研究进展[J].心血管病学进展,2019,(7):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
YUE Jian,HE Shenghu.Advances in the mechanism of PCSK9-induced atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(2):1000.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.009]
[4]武亚琳,梁斌,杨志明.NLRP3/IL-1β途径的促动脉粥样硬化作用及临床应用[J].心血管病学进展,2019,(6):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
WU Yalin,LIANG Bin,YANG Zhiming.The Role of NLRP3/IL-1in Atherosclerosis and Clinical Application[J].Advances in Cardiovascular Diseases,2019,(2):943.[doi:10.16806/j.cnki.issn.1004-3934.2016.06.026]
[5]李琦玉 ?张宁 陈婧 黄浙勇.动脉粥样硬化的抗血小板分子靶向治疗[J].心血管病学进展,2019,(5):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
LI Qiyu,ZHANG Ning,CHEN Jing,et al.Anti-Platelet Molecular Targeted Therapy or Atherosclerosis[J].Advances in Cardiovascular Diseases,2019,(2):701.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.010]
[6]侯冬华 郝丽荣.长正五聚蛋白3在动脉粥样硬化和心血管疾病中作用研究的新进展[J].心血管病学进展,2019,(5):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
HOU Donghua H AO Lirong.The Study of Atherosclerosis and Cardiovascular Diseases with Pentapycin 3[J].Advances in Cardiovascular Diseases,2019,(2):805.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.035]
[7]焦新峰 刘正霞 鲁翔.白介素-8在冠心病中的研究进展[J].心血管病学进展,2019,(8):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
JIAO Xinfeng,LIU Zhengxia,LU Xiang.Research Progress of Interleukin-8 in Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(2):1126.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.014]
[8]徐侨 刘正霞 鲁翔.白介素22在动脉粥样硬化和2型糖尿病中的作用[J].心血管病学进展,2019,(9):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
XU Qiao,LIU Zhengxia,LU Xiang.IL-22 in Atherosclerosis and Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(2):1260.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.019]
[9]石文坚 花蕾 孟祥光 袁义强.环状RNA在冠状动脉粥样硬化性心脏病中的研究进展[J].心血管病学进展,2019,(9):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
SHI Wenjian,HUA Lei,MENG Xiangguang,et al.CircRNA in Coronary Atherosclerotic Heart Disease[J].Advances in Cardiovascular Diseases,2019,(2):1286.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.026]
[10]代承忠 彭礼清 余建群 刘静 蒲华霞.双源CT血管成像评价经导管主动脉瓣置入术术前患者颈动脉斑块[J].心血管病学进展,2019,(8):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]
DAI Chengzhong,PENG Liqing,YU Jianqun,et al.Evaluation of Carotid Arteries Plaques in Patients Referred for TAVI with Dual-source CT Angiography[J].Advances in Cardiovascular Diseases,2019,(2):1182.[doi:10.16806/j.cnki.issn.1004-3934.2019.08.028]